Risks and Efficacy of RAS Blockade in Kidney Disease

This chapter explores the use of ACE inhibitors and ARBs in patients with advanced chronic kidney disease, focusing on potential risks such as hyperkalemia and acute kidney injury. It reviews randomized control trials to assess treatment efficacy and highlights the significance of patient demographics in determining the impact of these medications.